2015 Article This is an in depth article with a lot of

New Post Public Reply Private Reply Replies (0) Message Board
joey68
2015 Article

This is an in depth article with a lot of information. I'm sure any serious investors will read the majority of this article because they want to know what they are invested in.

Spectrascience is on the forefront of something huge...

http://doc.utwente.nl/97990/1/thesis_J_Spliethoff.pdf

Page 33
Quote:
Especially in the field of oncology, characterization of human
tissues by optical spectroscopy (spectral tissue sensing; STS) is considered to have major potential .


STS is often mediated by fiber-optics to establish contact between the tissue and the spectrometer.

Check out the graph on page 34:
(no image here, look at the PDF)

Quote:
Figure 3.1. Cumulative numbers of publications (red), patents (green) and clinical trials (blue) between 1990 and 2015 illustrating the increasing interest and advances in optical technology for oncological applications. The data shown was extracted from PubMed, Google Patents and Clinicaltrial.gov using
combinations of keywords (e.g. optical spectroscopy, fiber-optic, cancer


The chart is amazing. The increase in interest for advances in optical technology for oncological applications is exponential. Optical technology, like the WavSTAT4 is here to stay. I compare Optical biopsies to the 3D printing revolution currently underway. Most homes do not have a 3D printer; but in 10 years, we will all have one. In the same manner, most people never heard of optical biopsies (yet). But in 10 years they will be the standard.

Check out page 34

Quote:
LINKING RESEARCH WITH CLINICAL PRACTICE
The gap between original research and final clinical implementation is not specific for spectral tissue sensing, but is considered to be one of the key aspects of translation research in general . It has been stated that it takes more than one or two decades before the findings of original research become part of routine clinical practice


This is the most important sentence in this post:

It has been stated that it takes more than one or two decades before the findings of original research become part of routine clinical practice

This is part of the reason why it has taken SCIE so long to get to continual and predictable sales. We know naysayers try to get us to believe nothing has happened in so long, but we know in reality it takes years to create medical devices. I believe we are just about to commence sales and will see at least one 10Q this year or next with sales over $100,000.

The following is how Spectrascience is going to bring their product to the masses:

Quote:
An approach to address discrepancies between spectral data and histology is to integrate fiber-optics into standard tissue-sampling tools, such as a core biopsy needle or endoscopic
biopsy forceps
thereby linking spectral tissue sensing and

Go to page 38

Look at the first image

Quote:
The WavSTAT biopsy forceps for optical diagnosis based on laser-induced autofluorescence spectroscopy.


SCIE is way ahead of the game. Their tech has already addressed these discrepancies and is ready for the market. So here we go again. Yet ANOTHER article talking about the WavSTAT!

Go to page 174
Quote:
It is expected that STS will become an integral part of future medical practice.


Great times ahead for SCIE. Unless I read otherwise, I will continue to believe Spectrascience is going to be an integral part in a billion dollar industry.

Not investment advice. Don't invest based on this or any post.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Orvana's Bolivian Ramps & Covenant Pressure

Updated Category News Views 24

Orvana's Uphill Journey in Bolivia If you've been tracking Orvana Minerals (TSX: ORV, OTCQX: ORVMF), you know their Bolivian subsidiary, EMIPA, is in the thick of things. Filtration fixes are making noise, and EMIPA's scrambling to get its financial ducks in a row with some urgent maneuvers. Aiming Higher with Don Mario Orvana's Don Mario plant is trucking along with its...

Continue Reading
Potomac Edison Targets Virginia Grid Revamp by 2030

Updated Category News Views 82

Strengthening the Backbone of Virginia's Power Supply Ever had your lights flicker on a windy day and wondered if the power grid would hold? Potomac Edison, under the banner of FirstEnergy Corp., is stepping up with a game plan to fortify the electric spine of Virginia and its neighbors. They're diving into a multi-state adventure, rebuilding and erecting 138 kV...

Continue Reading
AAR's $1.9B Notes Offering and Strategic Moves

Updated Category News Views 59

A Look at AAR's Bold Move Big moves often come with big price tags, and AAR Corp's recent announcement is no exception. The aviation aftermarket titan recently declared a hefty $1.9 billion offering of senior notes, divided between 7.125% notes due 2031 and 7.375% notes maturing in 2034. It's a leap that signals their intent to snag a controlling interest in MRO Holdings,...

Continue Reading
Steven Johnson Boosts Latham's Tax Team in D.C.

Updated Category News Views 51

Another Day, Another Big Hire in D.C. You'd think the revolving doors at these law firms were tied to Wall Street's cycles. Latham & Watkins, one heavyweight in the legal arena, is pulling a classic power move, snapping up Steven Johnson for their Washington, D.C. office. He ain't just some guy off the street; Johnson's got a résumé that reads like a textbook on federal...

Continue Reading
Oracle's $20 Billion Offering: What Investors Need to Know

Updated Category News Views 29

Oracle's Big Play: A $20 Billion Offering Nobody said playing in the big leagues was easy, and Oracle seems to be doubling down on that idea. Today, they spilled the beans on their ambition to rake in a cool $20 billion through an offering of common stock and senior notes. For those of us who keep a close eye on NYSE:ORCL, this is more than just a number—it's a signal...

Continue Reading
CodeBoxx CrewKit Forge: Decentralizing AI Development

Updated Category News Views 71

Unboxing the Machine: CodeBoxx's Ambitious Move When you're talking about shakin' up the tech world, look no further than CodeBoxx and their CrewKit Forge. Unveiled at the Titan 100 Tampa Bay gala, this AI software factory is a beast—a one-meter cube ready to replace a battalion of developers. Imagine not the sterile data centers but this thing chilling in your office,...

Continue Reading
Amazon and CarbiCrete Innovate with Cement-Free Pavers

Updated Category News Views 88

Amazon Makes a Play for the Planet Look, I'm not one to sprinkle sugar on a cement-related chat, but I gotta say, this CarbiCrete deal has got my attention. Amazon, a titan known for its logistical empire, is diving headfirst into cement-free territory with CarbiCrete's products. In a world where cement production has been a stubborn carbon belcher, there's something big...

Continue Reading
Atlas Power Expands with Boyland Electric Acquisition

Updated Category News Views 114

The Strategy Behind Atlas Power's Expansion Atlas Power Partners, no stranger to sizzling ambitions, has galvanized its portfolio by roping in Boyland Electric. This latest maneuver unfolds as Atlas hustles to become the go-to network for residential generator services. It’s a clear bet on 'quality over flair'—an ethos echoed by their CEO, David Fischer, who champions...

Continue Reading
Ascletis Showcases Bold Moves in Obesity Drug Arena

Updated Category News Views 194

If you’ve been watching the developments in the world of obesity treatments, Ascletis Pharma is a name you'd do well not to ignore. With ObesityWeek 2026 on the horizon, these folks aren’t just talking—they’re putting their preclinical cards on the table and they’re noteworthy. Unveiling Future Contenders Ascletis is gearing up to present some of their...

Continue Reading
Anthropic's IPO Spurs Leverage Shares' New ETFs

Updated Category News Views 65

Taking a Gamble on AI's New Kid on the Block Here we stand on the edge of another potential AI stock bonanza. Anthropic’s got its sights set on going public, and folks are lining up to bite into what could be the next big generative AI feast. But it's Leverage Shares by Themes that's setting the scene for something a bit wilder—introducing some juicy leveraged and...

Continue Reading

Top 5 Most Recently Viewed Articles

Univest Securities Facilitates $15 Million Capital Raise for UPC

Updated Category News Views 195

Univest Securities Completes $15 Million Offering New York — Univest Securities, LLC, a prominent member of FINRA and SIPC known for its investment banking services, has recently wrapped up a notable registered direct offering for its client, Universe Pharmaceuticals INC (NASDAQ: UPC). This significant achievement heralds a new chapter for the pharmaceutical company....

Continue Reading
Cytek Biosciences Receives ISO 13485 Certification

Updated Category News Views 41

Cytek Biosciences Earns ISO 13485 Certification Today, Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that its reagent manufacturing facility in San Diego has received the EN ISO 13485:2016 Quality Management System (QMS) certification. This esteemed certification covers the design, development, manufacturing, and distribution of reagents and accessories, underscoring...

Continue Reading
Clearside Biomedical Engages in Chapter 11 to Enhance Value

Updated Category News Views 184

Clearside Biomedical Engages in Chapter 11 to Enhance Value Clearside Biomedical, Inc. (NASDAQ: CLSD) is embarking on a significant restructuring journey by filing for voluntary Chapter 11 bankruptcy. This strategic move aims to maximize stakeholder value through a structured process, facilitating an auction to sell the company’s assets. The decision, taken by...

Continue Reading
Transamerica Welcomes Ryan Parker to Lead Life Distribution Team

Updated Category News Views 324

Transamerica Appoints New Leader for Life Distribution Transamerica, a prominent name in the insurance sector, has recently made a significant move by appointing Ryan Parker as the head of Life Distribution. This strategic decision aims to strengthen the distribution of their life insurance products, catering to the critical needs of families striving for financial...

Continue Reading
Exploring VOSK's Top Artisan Candle Designs from Customers

Updated Category News Views 201

VOSK's Curated Collection of Artisan Candles VOSK, a renowned name in the world of handmade candles, recently shared insights into its most cherished designs based on customer feedback. This selection highlights products that have received high volumes of references and repeat purchases, showcasing a deep connection between quality craftsmanship and consumer preference....

Continue Reading